Prascend Tablets (Pergolide Mesylate) is an FDA approved oral dosage form of pergolide for the treatment of clinical signs associated with Equine Cushing’s Disease in horses. Prascend acts directly on the dopamine-producing neurons in the hypothalamus, helping to bring cortisol concentrations in the bloodstream back to near normal levels. It can take up to 6-12 weeks to see the full benefit of treatment. Each tablet contains 1mg of pergolide mesylate. Tablets are sold in boxes of 60 count and 160 count packages. Tablets are in foil wrapped sealed blister strips.

Regu-Mate Solution contains altrenogest, an oral progestin, to suppress estrus in mares to allow for a predictable occurrence of estrus following drug withdrawal. Each mL of Regu-Mate (altrenogest) Solution 0.22% contains 2.2 mg of altrenogest in an oil solution.

Levothyroxine sodium powder supplement for horses. For use in horses for correction of conditions associated with low circulating thyroid hormone (hypothyroidism). (Manufacturer – Vet A Mix)